Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
出版年份 2021 全文链接
标题
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
作者
关键词
-
出版物
LANCET ONCOLOGY
Volume 22, Issue 8, Pages 1103-1114
出版商
Elsevier BV
发表日期
2021-06-30
DOI
10.1016/s1470-2045(21)00245-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
- (2020) Weilun Fu et al. Frontiers in Immunology
- Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
- (2020) Benjamin Gesundheit et al. Frontiers in Oncology
- Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection
- (2020) Ashish H. Shah et al. JOURNAL OF NEURO-ONCOLOGY
- Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes
- (2018) Malte Mohme et al. CLINICAL CANCER RESEARCH
- Immunotherapy for brain tumors: understanding early successes and limitations
- (2018) Nicole A. P. Lieberman et al. Expert Review of Neurotherapeutics
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes after second surgery for recurrent glioblastoma: a retrospective case–control study
- (2018) Alysson Wann et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy for brain tumors: understanding early successes and limitations
- (2018) Nicole A. P. Lieberman et al. Expert Review of Neurotherapeutics
- Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
- (2018) E Antonio Chiocca et al. NEURO-ONCOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model
- (2017) Michael E. Barish et al. Stem Cells Translational Medicine
- Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
- (2016) Jana Portnow et al. CLINICAL CANCER RESEARCH
- Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters
- (2016) Julius Woongki Kim et al. Journal of Translational Medicine
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction
- (2014) R A Morshed et al. CANCER GENE THERAPY
- A Preclinical Evaluation of Neural Stem Cell–Based Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy
- (2013) Atique U. Ahmed et al. JNCI-Journal of the National Cancer Institute
- Neural Stem Cell-Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies
- (2013) K. S. Aboody et al. Science Translational Medicine
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- The Timing of Neural Stem Cell-Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma
- (2013) Alex L. Tobias et al. Stem Cells Translational Medicine
- Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis
- (2012) Yimin Xu et al. MOLECULAR BIOLOGY REPORTS
- Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges
- (2011) M. Kelly Nicholas et al. SEMINARS IN ONCOLOGY
- Neural stem cell systems: physiological players or in vitro entities?
- (2010) Luciano Conti et al. NATURE REVIEWS NEUROSCIENCE
- Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
- (2009) I V Ulasov et al. BRITISH JOURNAL OF CANCER
- Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells
- (2008) Jenilyn J. Virrey et al. AMERICAN JOURNAL OF PATHOLOGY
- Low-Dose Radiation Enhances Survivin-Mediated Virotherapy against Malignant Glioma Stem Cells
- (2008) S. Nandi et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started